M. Hoffman

发表

The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker

J. Atkinson, P. Maincent, M. Guerret, 1991, Pharmaceutical Research.

Effect of the microencapsulation of nanoparticles on the reduction of burst release.

A. Lamprecht, P. Maincent, A. Sapin, 2007, International journal of pharmaceutics.

Low Molecular Weight Heparin-Loaded Polymeric Nanoparticles: Formulation, Characterization, and Release Characteristics

V. Babak, T. Lecompte, P. Maincent, 2002, Drug development and industrial pharmacy.

Preparation and characterization of ethylcellulose microspheres containing 5-fluorouracil.

P. Maincent, M. Hoffman, C. Zinutti, 1994, Journal of microencapsulation.

Preparation and characterization of nanoparticles containing an antihypertensive agent.

Y. I. Kim, P. Maincent, M. Hoffman, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Influence of different physicochemical conditions on the release of indium oxine from nanocapsules.

P. Maincent, P. Thouvenot, M. Hoffman, 1998, Journal of biomedical materials research.

Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery.

P. Maincent, M. Hoffman, L. Marchal-Heussler, 1993, Pharmaceutical research.

Poly(ε-Caprolactone) Nanocapsules in Carteolol Ophthalmic Delivery

P. Maincent, M. Hoffman, L. Marchal-Heussler, 1993, Pharmaceutical Research.

Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations

P. Couvreur, P. Maincent, J. Spittler, 1990 .

In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits

T. Lecompte, P. Maincent, M. Marchand-Arvier, 2002, Circulation.

Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits.

P. Maincent, M. Marchand-Arvier, M. Hoffman, 2002, Journal of pharmaceutical sciences.

Preparation and Characterization of Heparin-Loaded Polymeric Microparticles

P. Maincent, M. Marchand-Arvier, M. Hoffman, 2002, Drug development and industrial pharmacy.

Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric Nanoparticles

P. Maincent, M. Marchand-Arvier, M. Hoffman, 2001, Drug delivery.

Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats

P. Couvreur, J. Kreuter, P. Maincent, 1992, Pharmaceutical Research.

Increase in the vascular residence time of propranolol-loaded nanoparticles coated with heparin.

J. Barré, A. Lamprecht, P. Maincent, 2008, Journal of nanoscience and nanotechnology.

[Value of the new drug carriers in ophthalmology: liposomes and nanoparticles].

P. Maincent, M. Hoffman, L. Marchal-Heussler, 1990, Journal francais d'ophtalmologie.

Influence of the casting solvent on the physico-chemical properties of 5-fluorouracil loaded microspheres

J. Benoit, P. Maincent, M. Hoffman, 1996 .

A 3 year stability study of tolbutamide solid dispersions and β-cyclodextrin complex

P. Maincent, F. Villieras, M. Hoffman, 1995 .

Bioavailability study of tolbutamide β-cyclodextrin inclusion compounds, solid dispersions and bulk powder

Philippe Maincent, P. Maincent, M. Hoffman, 1993 .

The preparation and evaluation of poly(ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug

A. Lamprecht, R. Bodmeier, P. Maincent, 2000 .

Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles.

R. Bodmeier, P. Maincent, M. Hoffman, 2005, International journal of pharmaceutics.

Effect of the formulation on the in-vitro release of propranolol from gellan beads.

C. Lombry, P. Maincent, M. Hoffman, 1999, International journal of pharmaceutics.

Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.

P. Maincent, M. Hoffman, N. Ubrich, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy.

P. Maincent, P. Thouvenot, M. Hoffman, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).

V. Préat, P. Maincent, C. François, 1996, Biomaterials.

Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique.

A. Lamprecht, C. Lehr, P. Maincent, 2000, International journal of pharmaceutics.

Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification.

A. Lamprecht, C. Lehr, P. Maincent, 1999, International journal of pharmaceutics.

Stability of parenteral ceftriaxone disodium solutions in frozen and liquid states: effect of freezing and microwave thawing.

A. Nicolas, P. Dixneuf, C. Finance, 1989, Journal of pharmaceutical sciences.

Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling.

J. Siepmann, A. Lamprecht, R. Bodmeier, 2003, Journal of controlled release : official journal of the Controlled Release Society.

Preparation of silicone microspheres by emulsion polymerization: application to the encapsulation of a hydrophilic drug.

P. Maincent, M. Hoffman, F. Kedzierewicz, 1998, Journal of microencapsulation.

Determination of heparin in aqueous solutions

B. Demoré, P. Maincent, M. Hoffman, 1998, Journal of clinical pharmacy and therapeutics.

Comparison of the biodistribution in mice of 111indium oxine encapsulated into poly(lactic-co-glycolic)-D,L-85/15 and poly(epsilon caprolactone) nanocapsules.

P. Maincent, P. Thouvenot, M. Hoffman, 1999, Journal of pharmaceutical sciences.

Formulation of Insulin-Loaded Polymeric Nanoparticles Using Response Surface Methodology

P. Maincent, N Ubrich, M Hoffman, 2005, Drug development and industrial pharmacy.

Microencapsulation of Low Molecular Weight Heparin into Polymeric Particles Designed with Biodegradable and Nonbiodegradable Polycationic Polymers

A. Lamprecht, P. Maincent, M. Hoffman, 2003, Drug delivery.

[Ways to improve ocular bioavailability for topical applications].

P. Maincent, M. Hoffman, L. Marchal-Heussler, 2000, Journal francais d'ophtalmologie.